Angiotensin II receptor blockers for the treatment of portal hypertension in patients with liver cirrhosis: a systematic review and meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Angiotensin II receptor blockers for the treatment of portal hypertension in patients with liver cirrhosis: a systematic review and meta-analysis of randomized controlled trials

Published:2018-02-22 Issue:4 Volume:187 Page:925-934
ISSN:0021-1265
Container-title:Irish Journal of Medical Science (1971 -)
language:en
Short-container-title:Ir J Med Sci

Author:

Yao Huijing,Zhang Chunqing^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/article/10.1007/s11845-018-1765-6/fulltext.html

Reference35 articles.

1. Garcia-Tsao G, Bosch J (2010) Management of varices and variceal hemorrhage in cirrhosis. N Engl J Med 362(9):823–832. https://doi.org/10.1056/NEJMra0901512

2. Tsochatzis EA, Bosch J, Burroughs AK (2014) Liver cirrhosis. Lancet 383(9930):1749–1761. https://doi.org/10.1016/S0140-6736(14)60121-5

3. Villanueva C, Graupera I, Aracil C, Alvarado E, Minana J, Puente A, Hernandez-Gea V, Ardevol A, Pavel O, Colomo A, Concepcion M, Poca M, Torras X, Rene JM, Guarner C (2017) A randomized trial to assess whether portal pressure guided therapy to prevent variceal rebleeding improves survival in cirrhosis. Hepatology 65(5):1693–1707. https://doi.org/10.1002/hep.29056

4. D'Amico G, Garcia-Pagan JC, Luca A, Bosch J (2006) Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review. Gastroenterology 131(5):1611–1624. https://doi.org/10.1053/j.gastro.2006.09.013

5. Procopet B, Berzigotti A (2017) Diagnosis of cirrhosis and portal hypertension: imaging, non-invasive markers of fibrosis and liver biopsy. Gastroenterol Rep (Oxf) 5(2):79–89. https://doi.org/10.1093/gastro/gox012

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Classical and Nonclassical Renin-Angiotensin-Aldosterone System in Liver Cirrhosis;The Renin Angiotensin System in Cancer, Lung, Liver and Infectious Diseases;2023

2. SYNTROPIC AND ASSOCIATED COMORBID LESIONS OF THE CARDIOVASCULAR SYSTEM IN PATIENTS WITH LIVER CIRRHOSIS;World of Medicine and Biology;2022

3. Novel therapeutics for portal hypertension and fibrosis in chronic liver disease;Pharmacology & Therapeutics;2020-11

4. HEP-Net opinion on the management of ascites and its complications in the setting of decompensated cirrhosis in the resource constrained environment of Pakistan;Pakistan Journal of Medical Sciences;2020-06-26

5. Pathways of hepatic and renal damage through non‐classical activation of the renin‐angiotensin system in chronic liver disease;Liver International;2019-11-04